| 1 |
34300575 | A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors. | 2021 Jul 15 |
2 |
| 2 |
33263997 | Recifin A, Initial Example of the Tyr-Lock Peptide Structural Family, Is a Selective Allosteric Inhibitor of Tyrosyl-DNA Phosphodiesterase I. | 2020 Dec 16 |
2 |
| 3 |
31878088 | Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy. | 2019 Dec 23 |
2 |
| 4 |
30191738 | Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy. | 2018 Dec |
1 |
| 5 |
25522766 | Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan. | 2015 Feb |
2 |
| 6 |
23913164 | TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells. | 2013 Oct |
2 |
| 7 |
19604089 | Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. | 2009 Jul |
1 |
| 8 |
19883083 | 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors. | 2009 Nov 26 |
1 |
| 9 |
18347181 | Irinotecan pharmacogenetics: influence of pharmacodynamic genes. | 2008 Mar 15 |
1 |
| 10 |
20301284 | Spinocerebellar Ataxia with Axonal Neuropathy, Autosomal Recessive – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 1993 |
1 |